J Pharma

from its establishment in 2005, j-pharma, a clinical stage bio-venture company with a special focus on membrane transporters, has been conducting an array of unique drug developments by hitoshi endou, md., ph.d., formerly a professor of kyorin university faculty of medicine. recently j-pharma has been placing the highest priority on the clinical development of its original inhibitors of l-type amino acid transporter 1 (“lat1”) for the treatment of advanced cancer patients who failed to benefit from standard chemotherapy.